Causal relationship between fertility nutrients supplementation and PCOS risk: a Mendelian randomization study
Frontiers in Endocrinology · 2024
DOI: 10.3389/fendo.2024.1420004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2024. Verfasst von Fang Shao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Mendelian Randomization Analysis, Dietary Supplements. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS), a prevalent endocrine disorder in women of reproductive age, is mainly ameliorated through drugs or lifestyle changes, with limited treatment options. To date, numerous researchers have found that fertility nutrient supplements may benefit female reproductive health, but their direct impact on polycystic ovary syndrome risk remains unclear.
Methods
Our research employs Mendelian Randomization to assess how fertility nutrients affect PCOS risk. Initially, we reviewed 49 nutrients and focused on 10: omega-3 fatty acids, calcium, dehydroepiandrosterone, vitamin D, betaine, D-Inositol, berberine, curcumin, epigallocatechin gallate, and metformin. Using methodologies of Inverse Variance Weighting and Mendelian Randomization-Egger regression, we examined their potential causal relationships with PCOS risk.
Results
Our findings indicate omega-3 fatty acids reduced PCOS risk (OR=0.73, 95% CI: 0.57-0.94, P =0.016), whereas betaine increased it (OR=2.60, 95% CI: 1.09-6.17, P =0.031). No definitive causal relations were observed for calcium, dehydroepiandrosterone, vitamin D, D-Inositol, and metformin ( P >0.05). Drug target Mendelian Randomization analysis suggested that increased expression of the berberine target gene BIRC5 in various tissues may raise PCOS risk (OR: 3.00-4.88; P : 0.014-0.018), while elevated expressions of curcumin target gene CBR1 in Stomach and epigallocatechin gallate target gene AHR in Adrenal Gland were associated with reduced PCOS risk (OR=0.48, P=0.048; OR=0.02, P =0.018, respectively).
Conclusions
Our research reveals that specific fertility nutrients supplementation, such as omega-3 fatty acids, berberine, and curcumin, may reduce the risk of PCOS by improving metabolic and reproductive abnormalities associated with it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
- Department of Histology and Embryology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
- Innovative Chinese Medicine Research Institute, Engineering Research Center of Modern Preparation Technology of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shao, F., Xu, S., Zhao, H., Zhang, F., Wang, X., & Wang, H. (2024). Causal relationship between fertility nutrients supplementation and PCOS risk: a Mendelian randomization study. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1420004
Vancouver
Shao F, Xu S, Zhao H, Zhang F, Wang X, Wang H. Causal relationship between fertility nutrients supplementation and PCOS risk: a Mendelian randomization study. Frontiers in Endocrinology. 2024. doi:10.3389/fendo.2024.1420004
BibTeX
@article{Shao2024,
author = {Shao, Fang and Xu, Shijia and Zhao, Haiyang and Zhang, Furong and Wang, Xin and Wang, Hui},
title = {Causal relationship between fertility nutrients supplementation and PCOS risk: a Mendelian randomization study},
journal = {Frontiers in Endocrinology},
year = {2024},
doi = {10.3389/fendo.2024.1420004}
}
EUVIMED